Active	Status	Sponsor type	Region	Phase	Filter
22 Active 5 Inactive 27 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

5 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Goll, Rasmus
NCT06233461: A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease	Recruiting	2	268	Europe, Canada, Japan, US, RoW	TAK-279, Placebo	Takeda	Crohn's Disease	09/26	07/27
NCT06254950: A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Ulcerative Colitis	Recruiting	2	207	Europe, Canada, Japan, US, RoW	TAK-279, Placebo	Takeda	Ulcerative Colitis	09/26	08/27
NCT05660109 / 2022-001656-41: A Study to Assess the Safety of TPM502 in Adults With Celiac Disease	Recruiting	2	42	Europe, RoW	TPM502, Placebo	Topas Therapeutics GmbH, Topas Therapeutics GmbH	Celiac Disease	05/24	05/24
Brudevold, Robert
NCT01397864: C1 Inhibitor Registry in the Treatment of Hereditary Angioedema (HAE) Attacks	Recruiting	N/A	300	Europe, RoW	rhC1INH or pdC1INH, Ruconest	Pharming Technologies B.V.	Hereditary Angioedema	01/25	01/25
Yksnøy, Øyvind
ASTEROID, NCT03446547: Ablative STEreotactic RadiOtherapy wIth Durvalumab (MEDI4736)	Recruiting	2	106	Europe	Durvalumab, Medi4736	Vastra Gotaland Region, AstraZeneca	NSCLC, Stage I	07/24	07/24
Sand, Kristoffer Øksenvåg
No trials found
Herje-Hofseth, Synnøve
No trials found
Nag, Kari Eline N
No trials found
Irgens, Karen
No trials found
Trust, Møre and Romsdal H
No trials found
Nygaard, Thomas
No trials found
Andersen, Jintana B
No trials found